Novo Nordisk rolls out Wegovy pill in the UAE — testing appetite outside the U.S. with first global launch

Key points

• In this article NVO NVO LLY Follow your favorite stocks CREATE FREE ACCOUNT Novo Nordisk is launching its weight loss pill Wegovy in the United Arab Emirates, the Danish drugmaker said Wednesday, marking its first launch outside the U.S. market.
• Novo's approach will be guided by patient demand, the readiness of healthcare professionals, and the strength of healthcare and telehealth infrastructure, said Emil Kongshøj Larsen, executive vice president, International Operations.
• "The UAE has demonstrated strong momentum across all of these areas, and we look forward to bringing Wegovy pill to additional select countries in the coming months," he said.
• The country's regulator, the Emirates Drug Establishment, approved the Wegovy pill for weight management and reducing the risk of cardiovascular events in high-risk patients earlier this week.
• Larsen told CNBC last month that Novo was "all in" on launching the Wegovy pill in overseas markets, and that it was a "major...